Stay updated on Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial

Sign up to get notified when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. The prior funding-status notice and Revision: v3.4.1 were removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:43:18.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a government funding notice noting potential delays in updates and the NIH Clinical Center's status, with guidance to check cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T00:00:41.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle and new metadata fields: Last Update Submitted that Met QC Criteria and Last Update Posted, along with a revision indicator: Revision: v3.4.0. Older items Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.3%
    Check dated 2026-01-28T00:18:11.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3 in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:35:40.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added a Locations section with California listed and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T08:09:53.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.1 to v3.3.2; there is no change to the study content, eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:12:56.000Z thumbnail image

Stay in the know with updates to Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.